Both nCounter and pathway analyses revealed reduced expression of chemokines, such as CXCL5 and CXCL8, which function as leukocyte attractants, in lesions from patients with KS and concurrent KAD compared with those with KS alone. Here, CXCL5 is linked to Kaposi's sarcoma.